Oral Colon-Responsive Traditional Chinese Medicine Components-Bimetallic Self-Assembled Nanosystem Enhances PD-1 Inhibitor Therapy for MSS Colorectal Cancer

Cancer immunotherapy has revolutionized how doctors treat disease, but it works like a key that only fits certain locks. For a specific type of colorectal cancer, where the cells have unstable genetic codes, drugs that block the immune system's "off switches" are often highly effective. However, the vast majority of colorectal cancer cases are different; their genetic codes are stable, and they create a quiet, cold environment inside the tumor that actively repels the body's natural defenses. In these stable tumors, the immune system's soldiers, known as T cells, are either absent or exhausted, unable to recognize or attack the cancer. Adding to this difficulty is a specific biological barrier: the cancer cells and immune cells in these tumors overproduce a protein that acts like a vacuum cleaner, sucking away a crucial chemical signal needed to keep the immune soldiers active. Without this signal, the immune system remains dormant, and standard immunotherapy drugs fail to work.

Researchers at the Nanjing University of Chinese Medicine and Suzhou Vocational Health College have developed a new approach to wake up this dormant immune system using a combination of traditional herbal ingredients and modern nanotechnology. They created a tiny, oral delivery system designed to survive the harsh acid of the stomach and release its contents specifically in the colon, where the cancer resides. This system is built from two natural compounds found in Chinese medicine, emodin and magnolol, which are held together by iron and copper ions. When these components assemble, they form a self-contained nanoparticle that does not require any synthetic carrier materials. The team coated these particles with a special polymer that acts as a protective shell, ensuring the medicine stays intact until it reaches the alkaline environment of the large intestine.

The logic behind this design addresses three distinct problems at once. First, the iron and copper ions inside the particle act as catalysts that generate a burst of reactive oxygen, a type of chemical stress that forces the cancer cells to die in a way that exposes their hidden identity to the immune system. Second, the emodin component helps mature the immune system's messengers, known as dendritic cells, teaching them to present the cancer's identity clearly to the T cells. Third, the magnolol component blocks the "vacuum cleaner" protein mentioned earlier, allowing the vital chemical signal to build up again and re-energize the exhausted T cells. By combining these three actions, the researchers aimed to turn the cold, silent tumor environment into a hot, active battlefield where the immune system can fight back.

To test this, the team first determined the perfect balance of ingredients. They found that mixing the herbal compounds and metal ions in equal parts created the most effective structure. They confirmed that this mixture could be assembled in a single step, resulting in a particle about 200 nanometers in size, which is roughly one-five-hundredth the width of a human hair. When they analyzed the structure, they saw that the metal ions and herbal molecules had locked together tightly, changing from their original crystalline forms into a more flexible, amorphous state. This change was crucial because it allowed the particle to dissolve and release its drugs only when the pH level rose, which happens when the particle moves from the acidic stomach to the neutral or slightly alkaline colon.

In laboratory tests, the researchers showed that this new system could survive the stomach acid without falling apart. When placed in a solution mimicking stomach fluid, the uncoated particles disintegrated immediately, but the coated version remained stable for hours. Once the environment became more alkaline, similar to conditions in the colon, the protective shell dissolved, and the particles released their cargo. Inside cancer cells, the particles triggered a massive increase in the reactive oxygen species, far more than the metal ions or herbal drugs could achieve on their own. This stress caused the cancer cells to display warning signals on their surface and release internal markers that attract immune cells. Furthermore, the system successfully blocked the protein that was draining the chemical signal, restoring the environment needed for T cells to function.

The researchers then moved to living mice with colorectal tumors implanted in their colons to see how the treatment worked in a whole body. They fed the mice the nanoparticles orally and tracked their movement. The results showed that the coated particles traveled safely through the stomach and accumulated in the colon and tumors, whereas uncoated particles were mostly trapped in the stomach or cleared from the body. When the team combined this oral treatment with a standard immune checkpoint inhibitor drug, the results were striking. While the standard drug alone had almost no effect on these stable tumors, and the herbal drugs alone showed only modest improvement, the combination therapy stopped tumor growth in more than 82 percent of the cases.

The treatment did not just shrink the tumors; it fundamentally changed the immune landscape inside them. The researchers observed that the tumors became flooded with active T cells, which multiplied and began attacking the cancer cells with renewed vigor. The number of these killer T cells increased by more than four times compared to untreated mice. Additionally, the treatment successfully restored the levels of the vital chemical signal within the tumor, reversing the exhaustion that had previously left the immune system helpless. The mice that received the combination therapy lived significantly longer, with some surviving up to 60 days, a marked improvement over the control groups.

Importantly, the study confirmed that this approach was safe for the animals. Throughout the treatment period, the mice did not lose weight, and their liver and kidney function remained normal. Detailed examinations of their organs showed no signs of damage or inflammation, suggesting that the metal ions and herbal compounds did not cause harmful side effects when delivered in this targeted manner. The researchers concluded that this oral, carrier-free nanosystem offers a promising strategy to overcome the resistance seen in stable colorectal cancers. By using a modular design that combines herbal monomers, metal ions, and a smart delivery coating, they created a treatment that can be taken by mouth, survives the journey through the digestive tract, and effectively reprograms the tumor to accept immunotherapy. This work provides a new blueprint for turning difficult-to-treat cancers into conditions that the body's own defenses can manage.